rosiglitazone has been researched along with HIV Coinfection in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 22 (70.97) | 29.6817 |
| 2010's | 9 (29.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendayan, R; Cummins, CL; Kara-Yacoubian, N; Kelschenbach, J; Omeragic, A; Sahin, C; Volsky, DJ | 1 |
| Albu, J; Chiu, YL; Donovan, D; Engelson, E; Ernst, J; Ginsberg, HN; Glesby, MJ; Ham, K; He, Q; Kotler, DP; Lesser, M; Muthukrishnan, V | 1 |
| Albu, JB; Engelson, ES; Glesby, MJ; He, Q; Kotler, DP | 1 |
| Albu, J; Chiu, YL; Christos, P; Donovan, DS; Engelson, ES; Ginsberg, HN; Glesby, MJ; Ham, K; Hammad, H; Kotler, DP; Leung, V; Zhu, YS | 1 |
| Carr, A; Cooper, DA; Emery, S; Law, M; Samaras, K; Wand, H | 1 |
| Ackermans, M; Blümer, RM; Endert, E; Reiss, P; Sauerwein, HP; Serlie, MJ; van der Valk, M | 1 |
| Bejjani, DE; Harrill, D; Hileman, C; McComsey, GA; O'riordan, MA; Rizk, N; Ross, AC; Storer, N; Tungsiripat, M | 1 |
| Magkos, F; Mantzoros, CS | 1 |
| Dogra, V; El-Bejjani, D; Harrill, D; Hileman, C; McComsey, GA; O'Riordan, MA; Rizk, N; Ross, AC; Storer, N; Tungsiripat, M | 1 |
| Díaz-Delfín, J; Domingo, P; Giralt, M; Villarroya, F; Wabitsch, M | 1 |
| Baldelli, F; Cipriani, S; D'Amore, C; Fiorucci, S; Francisci, D; Mencarelli, A; Renga, B; Schiaroli, E | 1 |
| Brathwaite, CE; Brebbia, JS; Fuhrer, J; Gelato, MC; McNurlan, MA; Mynarcik, DC; Quick, JL; Steigbigel, RT; Wax, MR | 1 |
| Ehrenborg, E; Eriksson, P; Fisher, RM; Hamsten, A; Kannisto, K; Korsheninnikova, E; Silveira, A; Sutinen, J; Yki-Järvinen, H | 1 |
| Häkkinen, AM; Halavaara, J; Järvinen, A; Ristola, M; Seppälä-Lindroos, A; Sutinen, J; Vehkavaara, S; Westerbacka, J; Yki-Järvinen, H | 1 |
| Currier, J | 1 |
| Grunfeld, C; Lee, GA; Mafong, DD; Mauro, T; Tien, P; Yu, S | 1 |
| Grinspoon, S; Hadigan, C; Kamin, D; Lazar, MA; Lehrke, M; Mazza, S | 1 |
| Carey, D; Carr, A; Cooper, DA; Emery, S; Feneley, MP; Kovacic, JC; Mallon, PW; Martin, A; Wand, H | 1 |
| Feldt, T; Häussinger, D; Kroidl, A; Kurowski, M; Oette, M; Sagir, A; Vogt, C; Wettstein, M | 1 |
| Carey, D; Carr, A; Cooper, DA; Emery, S; Martin, A; Rothwell, S; Wand, H | 1 |
| Cabezas, MC; de Koning, EJ; Hoepelman, AI; Joven, J; op't Roodt, J; Rabelink, TJ; van Wijk, JP | 1 |
| Janez, A; Karner, P; Maticic, M; Sharma, PM; Tomazic, J; Vidmar, L | 1 |
| Feldt, T; Fritzen, R; Goebels, K; Häussinger, D; Kambergs, J; Kappert, G; Kroidl, A; Oette, M; Vogt, C; Wettstein, M | 1 |
| Alonso-Villaverde, C; Camps, J; Castro Cabezas, M; Coll, B; de Koning, EJ; Ferre, N; Hoepelman, IM; Joven, J; Parra, S; Rabelink, TJ; Tous, M; van Wijk, JP | 1 |
| Alston-Smith, BL; Basar, MT; Fielding, RA; Grinspoon, S; Koletar, SL; Mulligan, K; Parker, RA; Schouten, JT; Wininger, DA; Yang, Y | 1 |
| Cavalcanti, RB; Cheung, A; Kain, KC; Raboud, J; Shen, S; Walmsley, S | 1 |
| Janez, A; Karner, P; Maticic, M; Sharma, P; Silic, A; Tomazic, J; Vidmar, L | 1 |
| Ahn, H; Ferris, R; Gelato, MC; McNurlan, MA; Mynarcik, DC; Qurashi, S | 1 |
21 trial(s) available for rosiglitazone and HIV Coinfection
| Article | Year |
|---|---|
Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial.
Topics: Abdominal Fat; Blood Glucose; Body Composition; Double-Blind Method; Female; Glucose Tolerance Test; HIV Infections; Homeostasis; Human Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Lipid Metabolism; Male; Middle Aged; Placebos; Recombinant Proteins; Rosiglitazone; Thiazolidinediones | 2013 |
The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.
Topics: Body Composition; Double-Blind Method; Fatty Liver; Female; Growth Hormone; HIV Infections; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Like Growth Factor I; Intra-Abdominal Fat; Liver; Male; Middle Aged; Rosiglitazone; Thiazolidinediones | 2016 |
Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation.
Topics: Abdominal Fat; Adiponectin; Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Drug Therapy, Combination; Female; HIV Infections; Human Growth Hormone; Humans; Hypoglycemic Agents; Interleukin-6; Male; Middle Aged; Obesity; Rosiglitazone; Thiazolidinediones; Young Adult | 2016 |
A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy.
Topics: Absorptiometry, Photon; Adiponectin; Adult; Antiretroviral Therapy, Highly Active; Body Composition; Calorimetry, Indirect; Double-Blind Method; Glucose; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Lipolysis; Male; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2009 |
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Cholesterol; Double-Blind Method; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; PPAR gamma; Reverse Transcriptase Inhibitors; Rosiglitazone; Thiazolidinediones; Thymidine | 2010 |
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placebo.
Topics: Adult; Anti-Retroviral Agents; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Cholesterol; Cytokines; Diabetes Mellitus; Endothelium, Vascular; Extremities; Female; HIV Infections; Humans; Inflammation; Lipodystrophy; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Tunica Intima | 2011 |
Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Composition; Female; Glucose; Glucose Clamp Technique; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Pilot Projects; Radiography; Rosiglitazone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV Infections; Humans; Hyperinsulinism; Hypertriglyceridemia; Interleukin-6; Leptin; Lipodystrophy; Liver; Male; Middle Aged; Organ Specificity; Plasminogen Activator Inhibitor 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Subcutaneous Tissue; Thiazolidinediones; Transcription Factors | 2003 |
Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
Topics: Adult; Antiretroviral Therapy, Highly Active; Body Composition; Cholesterol; Double-Blind Method; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Triglycerides | 2003 |
Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone.
Topics: Adult; CD4 Lymphocyte Count; Diabetes Mellitus, Lipoatrophic; Female; HIV Infections; Hormones, Ectopic; Humans; Hypoglycemic Agents; Male; Middle Aged; PPAR gamma; Resistin; Rosiglitazone; Thiazolidinediones | 2005 |
Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.
Topics: Adult; Anti-HIV Agents; Australia; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin Resistance; Male; Middle Aged; Risk Factors; Rosiglitazone; Thiazolidinediones; Vasodilation | 2005 |
Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial.
Topics: Anti-HIV Agents; Face; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Ultrasonography | 2005 |
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Blood Glucose; Brachial Artery; Endothelium, Vascular; Fatty Acids, Nonesterified; Glucose Tolerance Test; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Lipodystrophy; Male; Metformin; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vasodilation | 2005 |
Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cholesterol, HDL; Cholesterol, LDL; HIV Infections; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Prospective Studies; Protease Inhibitors; Rosiglitazone; Thiazolidinediones; Triglycerides | 2005 |
Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.
Topics: Adult; Antiretroviral Therapy, Highly Active; Body Composition; Female; Glucose Tolerance Test; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2006 |
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Aryldialkylphosphatase; Chemokine CCL2; Cholesterol, HDL; HIV; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Male; Metformin; Middle Aged; Postprandial Period; Rosiglitazone; Thiazolidinediones | 2006 |
Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.
Topics: Adult; Body Composition; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Hyperinsulinism; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones; Treatment Outcome; Waist-Hip Ratio | 2007 |
Complications & side effects. Disappointing result for rosiglitazone and lipodystrophy.
Topics: Antiretroviral Therapy, Highly Active; Body Composition; Double-Blind Method; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Placebos; Rosiglitazone; Thiazolidinediones | 2004 |
A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Fat Distribution; CD36 Antigens; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2007 |
Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial.
Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Blood Glucose; Drug Administration Schedule; Fasting; Follow-Up Studies; Glucose Tolerance Test; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Prospective Studies; Protease Inhibitors; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2007 |
Importance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV disease.
Topics: Adiponectin; Adult; Blood Glucose; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Middle Aged; Molecular Weight; Protein Isoforms; Rosiglitazone; Thiazolidinediones; Viral Load | 2008 |
10 other study(ies) available for rosiglitazone and HIV Coinfection
| Article | Year |
|---|---|
Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Brain; Cells, Cultured; Disease Models, Animal; HIV Core Protein p24; HIV Infections; HIV-1; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Neuroglia; Nitric Oxide Synthase Type II; Oxidative Stress; Pioglitazone; PPAR gamma; Rosiglitazone; Tumor Necrosis Factor-alpha | 2019 |
Limb fat wasting improves with rosiglitazone therapy.
Topics: Absorptiometry, Photon; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Placebos; Reverse Transcriptase Inhibitors; Rosiglitazone; Thiazolidinediones | 2009 |
Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
Topics: Absorptiometry, Photon; Adipokines; Adult; Antiretroviral Therapy, Highly Active; Body Composition; Feeding Behavior; Glucose; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Intra-Abdominal Fat; Lipid Metabolism; Male; Middle Aged; Rosiglitazone; Surveys and Questionnaires; Thiazolidinediones; Tomography | 2009 |
Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.
Topics: Adiponectin; Adipose Tissue; Antiretroviral Therapy, Highly Active; Dyslipidemias; Fatty Acids, Nonesterified; Glycerol; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Lipolysis; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
HIV-1 Tat protein impairs adipogenesis and induces the expression and secretion of proinflammatory cytokines in human SGBS adipocytes.
Topics: Adipocytes; Adipogenesis; Cytokines; Gene Expression Regulation; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Inflammation; Resveratrol; Rosiglitazone; Sesquiterpenes; Stilbenes; tat Gene Products, Human Immunodeficiency Virus; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |
The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.
Topics: Atherosclerosis; Cell Line; Cell Separation; gag Gene Products, Human Immunodeficiency Virus; Gene Expression Regulation; GTP-Binding Proteins; HIV Antigens; HIV Infections; HIV-1; Humans; Inflammation; Isoxazoles; Janus Kinases; Lipid Metabolism; Lipopolysaccharide Receptors; Macrophages; Monocytes; Neoplasm Proteins; Neutralization Tests; Phenotype; Phosphorylation; PPAR gamma; Receptors for Activated C Kinase; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; STAT1 Transcription Factor; Thiazolidinediones; Vaccination; Vidarabine | 2012 |
Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Metabolic update: better defining lipodystrophy and treating insulin resistance.
Topics: Case-Control Studies; Female; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipodystrophy; Male; Rosiglitazone; Thiazolidinediones; Triglycerides | 2003 |
Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy.
Topics: HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin; Lipomatosis; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Treatment Outcome | 2004 |
Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Area Under Curve; Biological Availability; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Interactions; Drug Monitoring; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Male; Metabolic Clearance Rate; Middle Aged; Rosiglitazone; Thiazolidinediones; Viral Load | 2005 |
Summaries for patients. HIV lipodystrophy: rosiglitazone or metformin?
Topics: Adipose Tissue; Adolescent; Adult; Aged; Blood Glucose; Brachial Artery; Endothelium, Vascular; Fatty Acids, Nonesterified; Glucose Tolerance Test; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Lipodystrophy; Male; Metformin; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vasodilation | 2005 |